U.S. MARKETS FOR INTERVENTIONAL CARDIOLOGY PRODUCTS

138 Pages | 45 Exhibits | 2016 Analysis | Forecasts Through 2020

OVERVIEW:
In the United States (U.S.), approximately 85.6 million adults have at least one type of cardiovascular disease (CVD), a broad group of disorders that affect the heart and circulatory system. Cardiovascular disease in all its forms accounts for more deaths than any other major cause in the U.S., including cancer, with one of every three deaths in the country due to CVD and over 2,200 people dying from the disease each day (or an average of one death from CVD every 40 seconds). Diseases/disorders of the heart are managed using a variety of methods including noninvasive imaging, open surgery, and catheter-based modalities. Interventional cardiology is a continually evolving area of medicine that involves the use of catheter-based, or transcatheter, tools and techniques to diagnose and treat coronary vascular and structural disorders. Today, interventional techniques are a mainstay for the diagnosis and treatment of patients with CHD and certain other types of CVD, as the transcatheter procedures typically are more cost-effective and less traumatic to patients than open surgical methods. The overall market for interventional cardiology products used in the treatment of coronary artery disease was valued at $3,345.1 million in 2015. Over the forecast period covered by this report, total sales are expected to increase at a compound annual growth rate of 1.2%, reaching an estimated $3,558.7 million by the year 2020.

This report will cover:

  • Interventional diagnostic and therapeutic products for the treatment of CVD;
  • Procedure and market forecasts for the years 2015 to 2020;
  • Key market drivers and limiters;
  • Estimated revenues and market shares for major U.S. competitors; and,
  • Analysis of lead products and emerging products/technologies.


TABLE OF CONTENTS:
EXECUTIVE SUMMARY

i. Diagnostic Interventional Cardiology Products
ii. Therapeutic Interventional Cardiology Products
iii. Methodology

Exhibit ES-1: Diagnostic Interventional Cardiology Systems Market Share, by Product Segment, 2015 and 2020
Exhibit ES-2: Therapeutic Interventional Systems Market Share, by Product Segment, 2015 and 2020

1. HEART DISEASE OVERVIEW

1.1 Coronary Heart Disease
	1.1.1 Atherosclerosis
	1.1.2 Angina Pectoris
	1.1.3 Myocardial Infarction
1.2 Hypertension
1.3 Cardiomyopathy
1.4 Congenital Heart Defects
1.5 Heart Failure
	1.5.1 Disease Development

Exhibit 1-1: Statistics for Selected Coronary Heart Disease Risk Factors
Exhibit 1-2: Angina Pectoris, Selected Statistics
Exhibit 1-3: Clinical Classification of AMI
Exhibit 1-4: Myocardial Infarction, Selected Statistics
Exhibit 1-5: Hypertension, Selected Statistics
Exhibit 1-6: Cardiomyopathy, Selected Statistics
Exhibit 1-7: Congenital Heart Defects, Selected Statistics
Exhibit 1-8: Summary, American College of Cardiology/American Heart Association Heart Failure Staging System
Exhibit 1-9: Heart Failure, Selected Statistics

2. DIAGNOSTIC INTERVENTIONAL CARDIOLOGY  PROCEDURES AND PRODUCTS

2.1 Coronary Angiography
	2.1.1 Procedure Volumes
	2.1.2 Products
	2.1.3 Market Forecast
	2.1.4 Competitors
2.2 Guidewire-Based Physiologic Intravascular Stenosis Assessment
	2.2.1 Procedure Volumes
	2.2.2 Products
	2.2.3 Market Forecast
	2.2.4 Competitors
2.3 Intracardiac Echocardiography
	2.3.1 Procedure Volumes
	2.3.2 Products
	2.3.3 Market Forecast
	2.3.4 Competitors
2.4 Intravascular Ultrasound
	2.4.1 Procedure Volumes
	2.4.2 Products
	2.4.3 Market Forecast
	2.4.4 Competitors
2.5 Optical Coherence Tomography
	2.5.1 Procedure Volumes
	2.5.2 Products
	2.5.3 Market Forecast
	2.5.4 Competitors

Exhibit 2-1: Diagnostic Interventional Cardiology, Combined Procedure Volumes Forecast, 2015-2020
Exhibit 2-2: Diagnostic Interventional Cardiology Products, Combined Market Forecast, 2015-2020
Exhibit 2-3: Coronary Angiography, Procedure Volumes Forecast, 2015-2020
Exhibit 2-4: Coronary Angiography Devices, Market Forecast, 2015-2020
Exhibit 2-5: 2015, Coronary Angiography Devices Market, Share by Supplier
Exhibit 2-6: Guidewire-Based Physiologic Intravascular Stenosis Assessment,  Procedure Volumes Forecast, 2015-2020
Exhibit 2-7: Physiologic Intravascular Stenosis Assessment Guidewires, Market Forecast, 2015-2020
Exhibit 2-8: 2015, Physiologic Intravascular Stenosis Assessment Guidewire Systems Market, Share by Supplier
Exhibit 2-9: Intracardiac Echocardiography, Procedure  Volumes Forecast, 2015-2020
Exhibit 2-10: Intracardiac Echocardiography Catheters,  Market Forecast, 2015-2020
Exhibit 2-11: 2015, Intracardiac Echocardiography Catheters Market, Share by Supplier
Exhibit 2-12: Intravascular Ultrasound, Procedure Volumes Forecast, 2015-2020
Exhibit 2-13: Intravascular Ultrasound Products, Market Forecast, 2015-2020
Exhibit 2-14: 2015, Intravascular Ultrasound Products Market, Share by Supplier
Exhibit 2-15: Cardiovascular Optical Coherence Tomography,  Procedure Volumes Forecast, 2015-2020
Exhibit 2-16: Cardiovascular Optical Coherence Tomography Systems, Market Forecast, 2015-2020

3. THERAPEUTIC INTERVENTIONAL CARDIOLOGY  PROCEDURES AND PRODUCTS

3.1 Percutaneous Transluminal Coronary Angioplasty
	3.1.1 Procedure Volumes Forecast
	3.1.2 Products
	3.1.3 Market Forecast
	3.1.4 Competitors
3.2 Coronary Stenting
	3.2.1 Procedure Volumes Forecast
	3.2.2 Products
	3.2.3 Market Forecast
	3.2.4 Competitors
3.3 Coronary Atherectomy
	3.3.1 Procedure Volumes Forecast
	3.3.2 Products
	3.3.3 Market Forecast
	3.3.4 Competitors
3.4 Coronary Thrombectomy
	3.4.1 Procedures Volumes Forecast
	3.4.2 Products
	3.4.3 Market Forecast
	3.4.4 Competitors
3.5 Transcatheter Septal Defect Repair
	3.5.1 Procedure Volumes Forecast
	3.5.2 Products
	3.5.3 Market Forecast
	3.5.4 Competitors

Exhibit 3-1: Therapeutic Interventional Cardiology, Combined Procedure Volumes Forecast, 2015-2020
Exhibit 3-2: Therapeutic Interventional Cardiology Products, Combined Market Forecast, 2015-2020
Exhibit 3-3: Percutaneous Transluminal Coronary Angioplasty, Procedure Volumes Forecast, 2015-2020
Exhibit 3-4: Percutaneous Transluminal Coronary Angioplasty Devices, Market Forecast, 2015-2020
Exhibit 3-5: 2015, Percutaneous Transluminary Coronary Angioplasty Devices Market, Share by Supplier
Exhibit 3-6: 2016, Selected Anti-Restenosis Agents
Exhibit 3-7: Coronary Stenting, Procedure Volumes Forecast, 2015-2020
Exhibit 3-8: Coronary Stent Systems, Market Forecast, 2015-2020
Exhibit 3-9: 2015, Coronary Stent Systems Market, Share by Supplier
Exhibit 3-10: Coronary Atherectomy, Procedure Volumes Forecast, 2015-2020
Exhibit 3-11: Coronary Atherectomy Systems, Market Forecast, 2015-2020
Exhibit 3-12: 2015, Coronary Atherectomy Devices Market, Share by Supplier
Exhibit 3-13: Coronary Thrombectomy, Procedure  Volumes Forecast, 2015-2020
Exhibit 3-14: Coronary Thrombectomy Systems, Market Forecast, 2015-2020
Exhibit 3-15: 2015, Coronary Thrombectomy Systems Market, Share by Supplier
Exhibit 3-16: Transcatheter Septal Defect Repair, Procedure Volumes Forecast, 2015-2020
Exhibit 3-17: Transcatheter Septal Defect Repair Devices, Market Forecast, 2015-2020
Exhibit 3-18: 2015, Transcatheter Coronary Septal Defects Repair Devices Market, Share by Supplier

APPENDIX:  COMPANY LISTING

BIBLIOGRAPHY


COMPANIES COVERED:

  1. Abbott Laboratories
  2. Abbott Vascular/Abbott Laboratories
  3. ACIST Medical Systems
  4. Alvimedica
  5. AngioDynamics
  6. Arrow International, Inc./Teleflex, Inc.
  7. ASAHI INTECC Company LTD
  8. Atrium Medical Corporation/ Maquet Holding/ Getinge Group
  9. Bayer AG
  10. Bayer HealthCare AG/ Bayer AG
  11. BioCardia
  12. Biosense Webster/ Johnson & Johnson
  13. Biosensors International Group LTD
  14. BIOTRONIK SE & Co, KG
  15. Blue Medical
  16. Boston Scientific Corporation
  17. Bracco Group
  18. B. Braun Melsungen AG
  19. Capture Vascular Systems
  20. Cardinal Health
  21. Cardia, Inc.
  22. Cardiovascular Systems, Inc.
  23. CeloNova Biosciences, Inc.
  24. Control Medical Technology
  25. Cook Group, Inc.
  26. Cook Medical/Cook Group
  27. Cordis Corporation/ Cardinal Health
  28. Covidien/ Medtronic
  29. DISA Vascular PTY LTD
  30. Edwards Lifesciences Corporation
  31. Elixir Medical Corporation
  32. eucatech AG
  33. Eurocor GmbH/ Opto Circuits India LTD
  34. General Electric Healthcare/ General Electric Company
  35. W.L. Gore & Associates, Inc.
  36. Hexacath
  37. IberHospiTex
  38. Infraredx/Nipro Corporation
  39. InSitu Technologies, Inc.
  40. Johnson & Johnson
  41. Kaneka Medical Products/ Kaneka Medix Corporation
  42. Kyoto Medical Planning Corporation LTD
  43. Maquet Holding/ Getinge Group
  44. Maxcor/Opto Circuits India LTD
  45. Medtronic, Inc.
  46. Merit Medical Systems, Inc.
  47. Micell Technologies, Inc.
  48. MicroPort Scientific Corporation
  49. Opsens
  50. OrbusNeich
  51. Philips Healthcare/Royal Philips
  52. REVA Medical, Inc.
  53. Siemens AG
  54. Siemens Healthcare/Siemens AG
  55. Spectranetics Corporation
  56. STENTYS
  57. St. Jude Medical, Inc.
  58. Terumo Interventional Systems/Terumo Corporation
  59. Translumina GmbH
  60. Vascular Concepts/Vascular Concepts Group
  61. Vascular Solutions, Inc.
  62. Volcano Corporation/Royal Philips
Contact Us

Need help finding medtech research? Let us help you!